GGrantIndex
← Search

DEVELOPING MORE POTENT, DUAL EXON-SKIPPING OLIGONUCLEOTIDE THERAPEUTICS FOR DUCHENNE MUSCULAR DYSTROPHY.

$0FY2024Defense Health AgencyDOD

Pacdna Llc, Natick MA

Investigators

View source on USAspending →
DEVELOPING MORE POTENT, DUAL EXON-SKIPPING OLIGONUCLEOTIDE THERAPEUTICS FOR DUCHENNE MUSCULAR DYSTROPHY. · GrantIndex